Breaking News
Get 40% Off 0
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March. Read full update
Close

Eckert & Ziegler BEBIG SA (EZBG)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Eckert & Ziegler historical data, for real-time data please try another search
16.300 0.000    0.00%
18/02 - Closed. Currency in EUR ( Disclaimer )
  • Volume: 0
  • Bid/Ask: 16.300 / 16.600
  • Day's Range: 16.200 - 16.300
Type:  Equity
Market:  Belgium
ISIN:  BE0974300320 
Eckert & Ziegler 16.300 0.000 0.00%

Eckert & Ziegler BEBIG SA Company Profile

 
Get an in-depth profile of Eckert & Ziegler BEBIG SA, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryHealthcare Equipment & Supplies
SectorHealthcare
Employees

-

Equity Type

ORD

As of February 18, 2019, Eckert & Ziegler BEBIG S.A. was acquired by Eckert & Ziegler Strahlen- und Medizintechnik AG. Eckert & Ziegler BEBIG S.A. through its subsidiaries, develops, manufactures, and sells radiation equipment and related products based on isotope technology. It offers IsoSeed for the treatment of prostate cancer; Mick TP/TPV Applicator System, a brachytherapy implantation technique that allows for seed placement adjustments during implant to adapt changes of prostate size and position; IsoCord, a seed chain that provides radiation protection; IsoStrand, a seed chain that consists of 10 IsoSeeds with 1.0 cm center-to-center spacing for protection against radiation; and needles for LDR brachytherapy. The company also offers IsoSeed I25.S17plus loose seeds for brain tumor treatment; SagiNova and MultiSource HDR (high dose rate) afterloader systems for the HDR brachytherapy applications; SagiPlan software for HDR treatment plans; and Cobalt-60 for various HDR brachytherapy treatments. In addition, it offers gynecological and rectal HDR applicators and accessories; CT/MR contour prostate template sets; tongue and mouth, and nasopharynx applicator sets; breast bridge sets; esophagus applicator and bronchus intraluminal sets; Harrison-Anderson-Mick applicators; and Valencia applicator sets. Further, the company provides products for the temporary brachytherapy of eye cancers, including Ru-106 eye applicators for the treatment of uveal melanoma and retinoblastoma; and I-125 ophthalmic seeds for use in COMS eye applicators to treat eye tumors, such as uveal melanomas and retinoblastomas, as well as offers radiotherapy accessories. It markets and sells its products to oncologists, radiologists, urologists, and medical physicists through a network of distributors and agents worldwide. The company was formerly known as International Brachytherapy s.a. and changed its name to Eckert & Ziegler BEBIG S.A. in June 2011. The company was founded in 1996 and is headquartered in Seneffe, Belgium.

Contact Information

Address Rue Jules Bordet Zone Industrielle C
Seneffe, 7180
Belgium
Phone 32 6 452 08 08
Fax 32 6 452 08 01
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

EZBG Comments

Write your thoughts about Eckert & Ziegler BEBIG SA
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email